Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCreightons Regulatory News (CRL)

  • There is currently no data for CRL

Acquisition

16 Feb 2016 17:10

RNS Number : 2543P
Creightons PLC
16 February 2016
 

 

For Immediate Release 16 February 2016

 

Creightons plc (the "Company", "Creightons" or "Cplc")

 

Acquisition of certain assets of Broad Oak Toiletries Ltd (in Administration) ("BOT")

 

The Company announces that today Potter & Moore (Devon) Ltd ("PMD"), a wholly-owned subsidiary of Creightons plc, has purchased certain assets of Broad Oak Toiletries Ltd (in Administration) to include all unencumbered plant and equipment but excluding assets subject to HP, all stock and the IP including formulations, manufacturing methods, manufacturing and component specifications.

BOT is a private UK company which operated in a similar area of the toiletries contract manufacturing market to the Company, mainly supplying small batch high value products to its customers. It is proposed that the assets being acquired will be used as part of the Company's operations in that market to increase capacity and the range of products available to customers. 

 

The last available audited accounts for BOT for the year ended 31 January 2015 reported a Loss before tax of £770,000 attributable to the assets subject to this purchase although this was based on Turnover of £19.081million. Given the current condition of BOT's business, the Company believes it can achieve sales of £3.2million for the year to 31 January 2017 thus making a positive contribution to the results of the Group. The Company anticipates that the wider range of production capabilities together with its existing excellent reputation for customer service will enable the Company to re-build relationships with BOT's customers and generate increased sales for the enlarged operation.

 

The total consideration for the purchase is £600,002 which will be paid in cash from the current reserves of the Company.

 

The gross value of the consideration amounting to £600,002 of the assets acquired will be allocated as follows in the consolidated accounts of Company:

- Fixed assets £540,000

- IP £10,002

- Stock £50,000

Total £600,002

 

Stock valued at £168,000 will be acquired by PMD for £50,000 and therefore the Company will account for this as a debit to Gross Assets but then a credit to goodwill as negative goodwill of £118,000. This is because PMD will acquire it as part of the transaction for £50,000 and may only be able to realise value from it if existing contracts are retained.

 

The Company anticipates that the additional assets will enable it to increase consolidated group sales by some £3.2million in the first full year through additional capacity, supplying new customers and offering existing customers products previously manufactured by BOT.

 

Neither PMD nor the Company has agreed to take on any employees from BOT, and the Company understands that all were made redundant before the acquisition of these assets. 

 

Speaking after the transaction had been completed, the Company's Chairman, Mr William McIlroy said: "We are very excited by this acquisition which complements the Company's existing production capabilities which we are confident will add to both the Company's sales and profits by enabling us to produce and supply new product ranges such as Soap, Candles and Powder products to an enlarged customer base who will benefit from our superior supply chain management."

 

End

 

For further information, contact Mr Paul Forster, MD UK Operations or Mr Nick O'Shea, Company Secretary on 01733 281000

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ACQDQLFFQLFBBBD
Date   Source Headline
2nd Sep 20208:25 amRNSPreliminary Results Presentation
2nd Sep 20207:00 amRNSPreliminary Results
25th Aug 202010:31 amRNSUpdate - publication of preliminary results
24th Aug 20202:00 pmRNSPrice Monitoring Extension
8th Jul 20208:58 amRNSDirector update and grants of share options
8th Jul 20208:56 amRNSUpdate on preliminary results
26th May 20209:42 amRNSHolding(s) in Company
13th May 20204:41 pmRNSSecond Price Monitoring Extn
13th May 20204:37 pmRNSPrice Monitoring Extension
11th May 202011:05 amRNSSecond Price Monitoring Extn
11th May 202011:00 amRNSPrice Monitoring Extension
3rd Apr 20204:40 pmRNSSecond Price Monitoring Extn
3rd Apr 20204:35 pmRNSPrice Monitoring Extension
26th Mar 20202:05 pmRNSSecond Price Monitoring Extn
26th Mar 20202:00 pmRNSPrice Monitoring Extension
18th Mar 20209:39 amRNSBlock listing Interim Review
7th Feb 20204:54 pmRNSDirector/PDMR Shareholding
7th Feb 20209:06 amRNSSecond Price Monitoring Extn
7th Feb 20209:00 amRNSPrice Monitoring Extension
27th Jan 20201:05 pmRNSDirector/PDMR Shareholding
16th Jan 20206:06 pmRNSDirector shareholding, exercise of options, TVR
6th Jan 202011:47 amRNSDirector/PDMR Shareholding
28th Nov 20194:47 pmRNSMary Carney
20th Nov 20199:05 amRNSSecond Price Monitoring Extn
20th Nov 20199:00 amRNSPrice Monitoring Extension
20th Nov 20197:00 amRNSInterim Financial Report
11th Nov 20193:32 pmRNSInterim Results Presentation
10th Oct 20192:03 pmRNSResult of Meeting
20th Sep 20191:22 pmRNSProperty purchase agreement, Circular publication
18th Sep 20197:00 amRNSBlock Listing Six Monthly Return
14th Aug 20191:05 pmRNSResult of AGM
27th Jun 20195:29 pmRNSReport & Accounts, AGM, Final Dividend Declaration
26th Jun 201911:05 amRNSSecond Price Monitoring Extn
26th Jun 201911:00 amRNSPrice Monitoring Extension
26th Jun 20197:00 amRNSPreliminary Results
25th Jun 201911:54 amRNSAcquisition of Balance Active Formula
20th Jun 20193:52 pmRNSFull Year 2019 Results Presentation
20th Jun 20197:00 amRNSFull Year 2019 Results Presentation
17th May 20197:00 amRNSFinal results timetable and trading update
1st May 20194:43 pmRNSDirector/PDMR Shareholding
1st Apr 20194:52 pmRNSIssue of Equity and TVR
28th Mar 20195:06 pmRNSDirector/PDMR Shareholding
19th Mar 20192:14 pmRNSReplacement: Listing Application
13th Mar 20195:04 pmRNSListing Application
25th Feb 20193:26 pmRNSChange of Auditor
14th Feb 20192:16 pmRNSChange of Auditor
20th Dec 20183:57 pmRNSDirector/PDMR Shareholding
10th Dec 201812:26 pmRNSExercise of share options
29th Nov 201812:45 pmRNSDirector/PDMR Shareholding
21st Nov 20187:00 amRNSHalf-year Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.